mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.02 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.04 |